| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |